CClinicalTrials.gg
Status unknownNCT02393651Updated Nov 28, 2018

Late LTP-like Plasticity Effects of tDCS in Subacute Stroke Patients

An interventional study of tDCS in Stroke and Hemiparesis, sponsored by Erasmus Medical Center. Status unknown at 1 site in Netherlands. Open to participants aged 18 Years to 79 Years. Per ClinicalTrials.gov, last updated 2018-11-28.

Sponsored by Erasmus Medical Center · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Nov 2018), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
48
Allocation
Randomized
Ages
18 Years to 79 Years
Sex
All
01

Study summary

Rationale: About 80% of stroke patients suffer motor impairments, but current therapies have limited effects on motor recovery. Therefore, investigating new potential therapeutic approaches is crucial. Transcranial Direct Current Stimulation (tDCS) is a form of non-invasive electrical stimulation where a weak current is applied through electrodes over the scalp. This stimulation is known to (1) induce changes in neuronal excitability -which can last up to one day with late LTP-like plasticity protocols in a polarity and site-specific manner, and (2) facilitate motor learning and stroke recovery. So far, several pilot studies have reported beneficial results from tDCS in both subacute and chronic stroke patients, but it's still unclear how tDCS should be repeated over multiple days to optimally enhance recovery and training effects. Using a late LTP-like plasticity protocol could increase effectiveness of standard clinical care rehabilitation sessions and thus enhance the effects of rehabilitation. Therefore, the investigators want to investigate how late LTP-like plasticity tDCS affects rehabilitation in subacute stroke patients. The outcome of this study can provide important guidelines on effective motor therapy during stroke rehabilitation.

Objective: Identify the effect of late LTP-like plasticity on motor rehabilitation during the subacute phase after stroke.

Study design: Double-blinded, randomized between-subjects trials. Study population: Subacute stroke patients. Main study parameters/endpoints: The primary outcome measure is the upper limb motor function during the subacute phase after stroke.

02

Conditions studied

  • Stroke
  • Hemiparesis

Browse trials for

03

In context

Stroke

7,287 studies on the registry are indexed under Stroke; 2,006 are open to participants now.

This study's planned enrollment of 48 is close to the median of 50 across 5,370 interventional studies indexed under Stroke.

Browse Stroke studies →

Lead sponsor

Erasmus Medical Center is the lead sponsor of 466 studies on the registry; 179 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 79 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Subacute stroke (within 1-4 weeks post stroke)
  • Acute hemiparesis (Fugl-Meyer Stage \< IV) with single thromboembolic non-hemorrhagic infarction documented by a neurologist
  • Aged 18-79

Exclusion criteria

Exclusion Criteria:

  • Absence of voluntary movement (Fugl-Meyer Stage \< III)
  • Head injury or the presence of intracranial metal or intracranial lesions
  • History of cranial irradiation
  • History of epilepsy
  • Presence of a pacemaker
  • Taking anticonvulsant or neuroleptic medication
  • Substance abuse
  • Inability to understand instructions
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
48 participants (estimated)

Study arms

  • Placebo comparator
    Sham

    Motor training of the affected upper extremity combined with sham tDCS.

    Device: tDCS

  • Experimental
    tDCS

    Motor training of the affected upper extremity combined with dual transcranial direct current stimulation (tDCS).

    Device: tDCS

Interventions

  • DevicetDCS

    Late LTP-like plasticity tDCS (2 times per week) for 4 weeks.

06

What researchers measure

Primary outcomes

  1. Change from baseline in Upper Extremity Fugl Meyer Assessment

    Time frame: Baseline, 1 week, 2 weeks, 4 weeks and 12 weeks

Secondary outcomes

  1. ARAT

    Time frame: Baseline, 1 week, 2 weeks, 4 weeks and 12 weeks

  2. Hand grip strength

    Time frame: Baseline, 1 week, 2 weeks, 4 weeks and 12 weeks

  3. 10-meter walk test

    Time frame: Baseline; 1 week, 2 weeks, 4 weeks and 12 weeks

  4. EuroQol-5D

    Time frame: 12 weeks

  5. Barthel Index

    Time frame: Baseline; 1 week, 2 weeks, 4 weeks and 12 weeks

  6. HADS

    Time frame: Baseline; 4 weeks and 12 weeks

  7. MoCA

    Time frame: Baseline; 4 weeks and 12 weeks

  8. Wong-Baker FACES Pain Rating Scale

    Time frame: Every stimulation session

07

Study locations

1 of 1 sites recruiting
  • Rijndam
    Rotterdam, Zuid-Holland 3015LJ, Netherlands
    Recruiting
08

References and documents

Publications

  • Elsner B, Kugler J, Pohl M, Mehrholz J. Transcranial direct current stimulation (tDCS) for improving activities of daily living, and physical and cognitive functioning, in people after stroke. Cochrane Database Syst Rev. 2020 Nov 11;11(11):CD009645. doi: 10.1002/14651858.CD009645.pub4. PubMed 33175411 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 28, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02393651
Lead sponsor
Erasmus Medical Center
Responsible party
Rick van der Vliet (MSc, Erasmus Medical Center) — Principal investigator
First posted
Mar 19, 2015
Start date
Mar 2015
Primary completion
May 2019 (estimated)
Completion
May 2019 (estimated)
Last update
Nov 28, 2018

Study contacts

Rick van der Vliet, MSc
Contact
r.vandervliet@erasmusmc.nl
+31622857402

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Nov 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion